Amount Of Curcumin Research Articles

Differential sensitivity of human mammary epithelial and breast carcinoma cell lines to curcumin.

Curcumin has anti-inflammatory, antiproliferative, and antitumor effects. To understand the chemopreventive mechanism of curcumin against human malignancies, the cellular and molecular changes induced by this agent in human mammary epithelial (MCF-10A) and breast carcinoma (MCF- 7/TH) cell lines were investigated. The human multidrug- resistant breast cancer cell line was 3.5 fold more sensitive to curcumin than the mammary epithelial cell line. Even though both cell lines accumulated a similar amount of curcumin, a significantly higher percentage of apoptotic cells was induced in breast cancer cells compared to a very low percentage of apoptosis in mammary epithelial cells. Incubation of breast cancer cells with 20 and 40 microM curcumin for 24 h induced G2 block and sub-G0/G1 cell population, respectively. Curcumin treatment caused a reduction in the expression of Ki67, PCNA, and p53 mRNAs in breast cancer cells. The human mammary epithelial cell line showed a down-regulation of p21 mRNA and an up-regulation of Bax mRNA expression with curcumin treatment. The results suggest that apoptosis is involved in the curcumin-induced inhibition of tumor cell growth, and genes associated with cell proliferation and apoptosis may be playing a role in the chemopreventive action of curcumin.

The Griess assay: suitable for a bio-guided fractionation of anti-inflammatory plant extracts?

In the field of inflammation research the inducible nitric oxide synthase (iNOS) became an important pharmacological target, since overproduction of nitric oxide (NO) after induction of this enzyme seems to be associated with numerous pathological conditions. NO released from cells can be detected and quantified photometrically as its stable product nitrite by a simple colorimetric reaction (Griess reaction). The aim of our study was to investigate whether this method might be suitable for the bio-guided fractionation of anti-inflammatory plant extracts. For this purpose we assayed extracts as well as fractions of the roots of Curcuma zanthorrhiza Roxb, which contain the known iNOS inhibitor curcumin, and compared the obtained activity with their curcumin content. Furthermore, leaf extracts of Betula pendula Roth, to which defined amounts of curcumin were added, were examined to clarify the question whether chlorophyll might interfere with the test system. The presented results suggest that the Griess assay is indeed suitable to guide fractionation of plant extracts in order to isolate highly active compounds. Factors, however, which might restrict the broad application of this assay are the limited selection of solvents which do not interfere with the system and high contents of chlorophyll in plant extracts.

A study on the fate of curcumin in the rat.

The uptake, distribution and excretion of curcumin in Sprague-Dawley rats has been studied. When administered orally in a dose of 1 g/kg, curcumin was excreted in the faeces to about 75%, while negligible amounts of curcumin appeared in the urine. Measurements of blood plasma levels and biliary excretion showed that curcumin was poorly absorbed from the gut. No apparent toxic effects were seen after doses of up to 5 g/kg. When intravenously injected or when added to the perfusate of the isolated liver, curcumin was actively transported into bile, against concentration gradients of several hundred times. The major part of the drug was however metabolized. In suspensions of isolated hepatocytes or liver microsomes 90% of the added curcumin was metabolized within 30 min. In view of the poor absorption, rapid metabolism and excretion of curcumin, it is unlikely that substantial concentrations of curcumin occur in the body after ingestion.